Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief, VBCC;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
Authored Items
Videos
February 4, 2021 is #WorldCancerDay! Please join AVBCC Co-Chair Burt Zweigenhaft in sharing your #IAmAndIWill statement and make a pledge to continue to work on improving cancer care across the globe. Read More ›
AVBCC COVID-19 Webcast Series
It is a Herculean effort to develop a novel vaccine on an unprecedented timeline. Experts discuss the latest research regarding the development of vaccine candidates for the COVID-19 virus and some of the issues that will need to be addressed when a successful candidate has been identified, including clinical trial enrollment, manufacturing, and distribution. Read More ›
By Sibel Blau, MD; Bruce Feinberg, DO; William Mitchell, MD; Amy Valley, PharmD; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Community oncology practices say they are recovering from the COVID-19 pandemic and keeping their eye on the goal of value-based care. The strategies they are using to accomplish these initiatives include innovation, long-term integration of telehealth, and the leveraging of advanced practice professionals. Read More ›
By Andrea Dwyer, BS; Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN; Brenda Nevidjon, MSN, RN, FAAN; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
The COVID-19 pandemic has created significant barriers to care, which can lead to increased mortality rates for thousands of patients with cancer. Nurses and nurse navigators are focused on using their skills and experience to combat this trend. Ongoing efforts include educating patients on the importance of undergoing cancer screenings, utilizing telehealth services to enhance communication with patients, addressing staffing shortages, and taking the necessary steps for preparing for potential spikes in COVID-19 cases. Read More ›
AVBCC COVID-19 Webcast Series
Although several of the financial indicators in oncology have recovered to pre-pandemic levels following dramatic declines that occurred earlier in the year, there are still significant challenges ahead. How will providers manage the backlog? What will happen to patients’ insurance coverage? How will oncology practices survive and thrive in a post–COVID-19 world? Read More ›
By Naomi Gutierrez; Lisa Harrison, RPh; Duane Kembel; Patrick Schmidt; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
From the management of extended payment terms and performance-based agreements, to the potential impact of the proposed 2021 Medicare rules and the impending shortages of immune globulin, wholesale suppliers discuss how the COVID-19 pandemic continues to affect the oncology supply chain, what is being done to help practices, and what challenges lie ahead. Read More ›
By Bob Gold; Rick Lee; Brian Leyland-Jones, MD; Debra Patt, MD, PhD, MBA; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Can the use of telehealth services help to address the upcoming burden of late cancer diagnoses, improve the co-management of chronic conditions, and give patients more power over their own health? During a recent AVBCC webinar, a panel of experts explored this question as they discussed the potential role of wearables, remote monitoring and communication, and other innovative technology for improving care for patients with cancer. Read More ›
By Rob Butcher; John de Groot, MD; Adam Gadzinski, MD, MS; Robyn Gartrell, MD, MS; Denise McDade; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
With many clinical trials on hold and COVID-19 studies the only new trials opening up, how are cancer researchers adapting to the new environment? Can lessons from COVID-19 facilitate improved clinical trial recruitment and retention in the future? Read More ›
By Deborah Kamin, RN, PhD; Ted Okon, MBA; John O’Brien, PharmD, MPH; Jayson Slotnik, JD, MPH; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Telehealth reimbursement. 340B. Drug pricing negotiations. There’s been a lot of action on healthcare-related proposals in Washington in recent weeks. What’s likely to last, and what is just “political theater”? AVBCC’s panel of experts has the inside scoop. Read More ›
AVBCC COVID-19 Webcast Series
With the chaos in the workplace and in healthcare caused by the COVID-19 pandemic, experts predict that most major employers will not be looking to add any more disruption with significant changes to their benefit plans for 2021. Read More ›
By Marianne Gandee; Gerry Gleeson, MBA; Rena Goins; Arthur Hirt; Alan Tubbs; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Initiatives to expand patient access programs, strategies to secure the supply chain, and updates on vaccine trials: leaders from top pharmaceutical manufacturers discussed their companies’ ongoing response to the worldwide pandemic in this AVBCC webcast. Read More ›
AVBCC COVID-19 Webcast Series
When oncology practices, ranging from small community clinics to larger hospital-based programs, were required to adapt their systems virtually overnight in response to the COVID-19 health crisis, almost no one anticipated that these would be long-term changes. However, as September approaches with no end in sight, it has become clear that oncologists will need to adapt revenue cycle management to long-term pandemic-related changes. Read More ›
By Michael Diaz, MD; Barbara L. McAneny, MD; Ted Okon, MBA; Kashyap Patel, MD; Debra Patt, MD, PhD, MBA; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
As many full-service hospitals and health systems remain overwhelmed due to the COVID-19 pandemic, community cancer providers have been able to offer certain services to patients that may not be available at other institutions. How have these providers adapted to meet patients’ changing needs, and how are they keeping their doors open under unprecedented pressure? Read More ›
By Al B. Benson III, MD; Howard “Skip” Burris, III, MD, FACP, FASCO; Christian Downs, MHA, JD; Timothy Kubal, MBA, MD; Julian Schink, MD; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
From shuttered laboratory experiments and interrupted clinical trial enrollments to a “shadow curve” of delayed cancer diagnoses, comprehensive cancer centers and integrated delivery networks (IDNs) across the country continue to grapple with the fallout from COVID-19. Read More ›
By Michael Kolodziej, MD; Bryan Loy, MD, MBA; Lee N. Newcomer, MD, MHA; Steven Peskin, MD, MBA, FACP; Michael Sherman, MD, MBA, MS; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
One of the most significant questions for payers in the COVID-19 health ecosystem is, “Will reimbursement parity for telehealth services continue?” Leading representatives of major managed care organizations debate the prospects. Read More ›
By Elizabeth Franklin, LGSW, ACSW; Patricia J Goldsmith; Amy Niles, MBA; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials. Read More ›
By Scott Freeswick, MS, PharmD; Niesha Griffith, RPh, MS, FASHP; Chris Marcum, PharmD; Ali McBride, PharmD, MBA; Stacey McCullough, PharmD; Bhavesh Shah, RPh, BCOP; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Shortages, inventory management, and challenges of in-home care were just a few of the topics in AVBCC’s wide-ranging webinar on how COVID-19 is affecting oncology pharmacy. Read More ›
By Roger Brito, DO; Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP, FAAN; Michael Kolodziej, MD; Barbara L. McAneny, MD; Steven Peskin, MD, MBA, FACP; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
The COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks? Read More ›
By Bellinda Conte; Ann Ford; Femida Gwandry-Sridhar, PhD; Nancy Kaszak; Lisa Mazur; Kenneth Miller, MD; Christina Naso; Vernessa Pollard; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt
Videos
This webinar highlights the ways telehealth can provide the vital and essential care demanded within the field of oncology, with a focus on rural health, palliative care, digital therapeutics, clinical trials, home chemotherapy infusion, and more. Read More ›
By David DeRemer, PharmD, BCOP, FCCP, FHOPA; Michael Joyner, MD; Maurie Markman, MD; Kevin O’Hayer, MD, PhD; Bhavesh Shah, RPh, BCOP; Mark Sloan, MD; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today? Read More ›
By Gabriela Dieguez, FSA, MAAA; Pamela Pelizzari, MPH; Bruce S. Pyenson, FSA, MAAA; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
In this webcast, 3 experts from the independent actuarial firm, Milliman, discussed data on the impact of the COVID-19 pandemic on insurance utilization and costs. The panel explored several factors that may lead to healthcare reform in the months ahead, including the way in which patients and providers approach deferred or avoidable care. Read More ›
AVBCC COVID-19 Webcast Series
The COVID-19 pandemic will have far-reaching economic implications in the United States and abroad for the foreseeable future. During this session, Murray Aitken, MBA, Director, IQVIA Institute, presented emerging data regarding some of the ways in which the pandemic is affecting the US economy. Read More ›
By Andrea Dwyer, BS; Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN; Brenda Nevidjon, MSN, RN, FAAN; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Sally Werner, RN, BSN, MSHA; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Nurses are on the frontlines of healthcare delivery. In this panel, distinguished nursing professionals discussed topics and issues that have arisen during the pandemic. Led by healthcare educator Lillie D. Shockney, the comprehensive panel covered some of the myriad issues nurse navigators confront now, including rising cancer rates in an aging population, and a decline in numbers of oncology nurses and oncologists. Read More ›
By Deborah Kamin, RN, PhD; Ted Okon, MBA; John O’Brien, PharmD, MPH; Jayson Slotnik, JD, MPH; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
The federal government is an active participant in shaping healthcare policy and delivering care. The panelists in this session addressed the government’s response to COVID-19 and weighed in on some of the issues that their agencies frequently encountered as medical practices grapple with the new normal. Read More ›
By Murray Harber; Art Taft; Karen van Caulil, PhD; F. Randy Vogenberg, PhD, RPh, FASHP; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Employers continue to face significant challenges as they strive to provide healthcare coverage for their employees during the COVID-19 pandemic. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts explore solutions for some of the issues arising in a vastly changed healthcare market, and strategies for improving the way in which health benefits are conceived and implemented. Read More ›
By Bob Gold; Karen Keown, RN; Rick Lee; Brian Leyland-Jones, MD; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Telehealth continues to play a critical role in providing healthcare services to patients during the COVID-19 pandemic. In a webcast titled COVID-19: Impact on Telehealth, Rick Lee, Executive Chairman, Healthy Platforms and CancerLife, along with a panel of experts, discussed the benefits and ongoing challenges associated with the use of telemedicine and the far-reaching impact of this technology beyond the current crisis. Read More ›
By Rob Butcher; Craig Eagle, MD; Tom Lynch, MD; Maurie Markman, MD; Julie Saba, MD, PhD; Richard Schilsky, MD, FACP, FSCT, FASCO; Jedd Wolchok, MD, PhD, FASCO; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Researchers and clinical investigators are facing a series of unprecedented challenges as they adjust to necessary changes to their work environment resulting from the COVID-19 crisis. In this discussion, moderated by Rob Butcher, CEO, Swim Across America, a panel of researchers discuss the impact of the pandemic on conditions in laboratories, and how graduate students have had to adjust to interruptions in their career trajectories. Read More ›
By Michael Ganio, PharmD; Chris Marcum, PharmD; Ali McBride, PharmD, MBA; Stacey McCullough, PharmD; Bhavesh Shah, RPh, BCOP; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
In this discussion, moderated by Niesha Griffith, RPh, MS, FASHP, CPO (interim), a panel of oncology pharmacists discuss the impact of the COVID-19 pandemic on their practices, the increase in the use of new technologies as a result of recent events, and how the influx of patients expected in the coming weeks will affect their daily operations. Read More ›
By Roy Baynes, MD, PhD; Rena Goins; Mark Hagler, MBA; Bruce Wilson; Bryon Wornson; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Pharmaceutical support and innovation are vital to the effective treatment of patients with cancer. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discussed the importance of maintaining an adequate supply of medicines for patients, and the need for philanthropic programs to ensure patients will be able to continue their medications, even if they lose their health insurance. Read More ›
By Lucio Gordan, MD; Ted Okon, MBA; Debra Patt, MD, PhD, MBA; Jeff Patton, MD; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Large community care centers remain committed to providing necessary treatment to patients with cancer during the COVID-19 pandemic. In this discussion, moderated by Ted Okon, MBA, a panel of experts discuss the ongoing challenges that oncology providers face as they navigate an evolving healthcare ecosystem, and provide valuable insights on how practices may continue to deliver care in the months ahead. Read More ›
By Al B. Benson III, MD; Linda D. Bosserman, MD, FACP; Christian Downs, MHA, JD; Julian Schink, MD; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
As a result of the ongoing COVID-19 pandemic, comprehensive cancer care centers have been tasked with significantly altering their strategies for the delivery of care. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discuss some of the changes that have already been implemented at their centers and future considerations for healthcare systems as they focus on providing safe and effective care on the road to recovery. Read More ›
By John Fox, MD; Michael Kolodziej, MD; Bryan Loy, MD, MBA; Steven Peskin, MD, MBA, FACP; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Issues surrounding healthcare insurance continue to unfold in light of the recent COVID-19 pandemic. In this discussion, a panel of managed care experts, moderated by Michael Kolodziej, MD, explore strategies for reducing the total cost of care for patients with cancer and addressing the economic and administrative burdens that practices and payers are facing as a result of the crisis. Read More ›
By Elizabeth Franklin, LGSW, ACSW; Patricia J Goldsmith; Daniel J. Klein; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series
Addressing the significant physical and psychosocial needs of patients with cancer during the COVID-19 crisis remains a top priority for healthcare providers. In this discussion, moderated by Elizabeth Franklin, PhD, MSW, a panel of specialists explore efforts underway to advocate for patients who are coping with stress, anxiety, and various economic burdens. Read More ›
AVBCC COVID-19 Webcast Series
How does COVID-19 affect the distribution channels that deliver crucial medicine and other supplies for patients with cancer? In ths discussion, thought leaders in the wholesale drug distribution segment focused on the disruption and interventions brought about by the COVID-19 pandemic. Read More ›
AVBCC COVID-19 Webcast Series
In this webcast, Brian Gockerman, Managing Director at Unlimited Systems, begins by discussing the stabilization of cancer care programs, the potential implications of telehealth, the decline of newly referred patients, and what to prepare for in the future. Parag Shah, President, Practice Solutions at Integra Connect, continues the conversation by discussing how to keep your team engaged when working remotely, the shift of solution providers and telehealth, payer challenges, and solutions to some of these issues. Read More ›
AVBCC COVID-19 Webcast Series
The Association for Value-Based Cancer Care (AVBCC) webcast was introduced by Dr Zweigenhaft, Founder of AVBCC, who assembled an exceptional group of experts from across the country to discuss the COVID-19 outbreak and its impact on the healthcare industry. After a few quick welcoming remarks to allow more time for the fast-moving presentations, Dr Zweigenhaft introduced Dr Hudis, who briefly presented ASCO’s outlook on the crisis. Read More ›
AVBCC COVID-19 Webcast Series
A discussion articulating the challenges facing cancer care in the current COVID-19 crisis by some of the top thought leaders, faculty, and key opinion leaders. Read More ›
Videos
Watch AVBCC Co-Founder and Chairman Burt Zweigenhaft as he explains what differentiates the AVBCC Summit from other oncology meetings and why you can't afford to miss out on this unique gathering of stakeholders from all facets of the cancer care spectrum. Read More ›
Videos
Program Chair, Burt Zweigenhaft, describes the main mission of the Association for Value-Based Cancer Care. Read More ›